Lyndsey Flanagan


I completed a BSc in Biochemistry in 2017 and an MSc in Neuropharmacology in 2018 at the National University of Ireland, Galway (NUIG). The research project focused on the investigating the effects of Peroxiredoxin 6 siRNA knockdown on mitochondrial dynamics in SH-SY5Y neuroblastoma cells. From then I worked as an assistant scientist in PPD gaining GMP laboratory experience, allowing me an opportunity to gain technical experience and fuel my passion for research.

I started a Breakthrough Cancer Research Funded PhD in Dr. Ní Chonghaile’s research group in 2020. I am investigating the apoptotic BCL-2 family in multiple myeloma, with the aim of identifying novel therapeutic combinations using innovative BH3 profiling technology.

%d bloggers like this: